Intellectual Property India Publishes Patent Application for 'Compounds And Their Use For Treatment Of Hemoglobinopathies' Filed by Bristol-Myers Squibb Company

MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517052617 A) filed by Bristol-Myers Squibb Company, Princeton, U.S.A., on May 30, for 'compounds and their use for treatment of hemoglobinopathies.'

Inventor(s) include Cummins, Thomas J.; Cashion, Daniel K.; Edwards, Jacob T.; Lopez-Girona, Antonia; Hansen, Joshua; Johnson, Scott Arne; Nagy, Mark A.; Oberg, Kevin M.; Powers, Hannah L.; and Tamo, Giorgio.

The application for the patent was published on June 13, under issue no. 24/2025.

According to the abstract released by the Intellectual Property India: "Disclosed herein are compounds and methods for the prevention and/or treatment of hemoglobinopathies. Also provided herein are such compounds for use in such methods. Also disclosed herein are pharmaceutical compositions comprising such compounds for use in such methods of preventing or treating hemoglobinopathies."

The patent application was internationally filed on Nov. 03, 2023, under International application No.PCT/US2023/078600.

Disclaimer: Curated by HT Syndication.